InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Sumner Michael John. Officer active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. Aggregated, 10 reports have been recorded. Activity tracked since 15 May 2025. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Sumner Michael John is a declarant linked to INOVIO PHARMACEUTICALS, INC., where his listed role is Chief Medical Officer. The file shows 4 filings in total, and the sampled recent filings cover the period from 2023-07-03 to 2025-02-28, with the modal transaction nature listed as option exercise.